1. |
陆月明,顾秀莲.急性呼吸窘迫综合征研究进展.中华流行病学杂志,2005,26:463-465.
|
2. |
García-González MJ, Domínguez-Rodríguez A, Ferrer-Hita JJ.Unusual etiology of acute lung injury in a patient with acute myocardial infarction.Int J Cardiol,2007,117:e95-97.
|
3. |
Ware LB.Prognostic determinants of acute respiratory distress syndrome in adults:impact on clinical trial design.Crit Care Med,2005 ,33:S217-222.
|
4. |
Kondili E,Xirouchaki N,Vaporidi K,et al.Short-term cardiorespiratory effects of proportional assist and pressure-support ventilation in patients with acute lung injury/acute respiratory distress syndrome.Anesthesiology,2006,105:703-708.
|
5. |
Frutos-Vivar F,Nin N,Esteban A.Epidemiology of acute lung injury and acute respiratory distress syndrome.Curr Opin Crit Care,2004,10:1-6.
|
6. |
Rubenfeld GD,Herridge MS.Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome.Am J Respir Crit Care Med,2001,163:1376-1383.
|
7. |
Ware LB,Matthay MA.Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome.Am J Respir Crit Care Med,2001,163:1376-1383.
|
8. |
Calandra T,Roger T.Macrophage migration inhibitory factor:a regulator of innate immunity.Nat Rev Immunol,2003:791-800.
|
9. |
Madtes DK,Rubenfeld G,Klima LD,et al.Elevated transforming growth factor-alpha levels in bronchoalveolar lavage fluid of patients with acute respiratory distress syndrome.Am J Respir Crit Care Med,1998,158:424-430.
|
10. |
Steinberg KP,Hudson LD,Goodman RB,et al.Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome.N Engl J Med,2006,354:1671-1684.
|
11. |
Ware LB,Eisner MD,Thompson BT,et al.Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury. Am J Respir Crit Care Med,2004,170:766-772.
|
12. |
Eisner MD,Parsons P,Matthay MA, et al.Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury.Thorax,2003,58:983-988.
|
13. |
Sorensen GL,Husby S,Holmskov U,et al.Surfactant protein A and surfactant protein D variation in pulmonary disease.Immunobiology,2007,212,381-416.
|
14. |
Sato H,Callister ME,Mumby S,et al.KL-6 levels are elevated in plasma from patients with acute respiratory distress syndrome.Eur Respir J,2004,23:142-145.
|
15. |
Lang JD,McArdle PJ,O’Reilly PJ,et al.Oxidant-antioxidant balance in acute lung injury.Chest,2002,122:314S-320S.
|
16. |
Marshall RP,Bellingan G,Webb S,et al.Fibroproliferation occurs early in the acute respiratory distress syndrome and impacts on outcome.Am J Respir Crit Care Med,2000,162:1783-1788.
|
17. |
Clark JG,Milberg JA,Steinberg KP,et al.Type III procollagen peptide in the adult respiratory distress syndrome.Association of increased peptide levels in bronchoalveolar lavage fluid with increased risk for death.Ann Intern Med,1995,122:17-23.
|
18. |
Chesnutt AN,Matthay MA,Tibayan FA,et al.Early detection of type III procollagen peptide in acute lung injury. Pathogenetic and prognostic significance.Am J Respir Crit Care Med,1997,156:840-845.
|
19. |
Goodman RB,Pugin J,Lee JS,et al.Cytokine-mediated inflammation in acute lung injury.Cytokine Growth Factor Rev,2003,14:523-535.
|
20. |
Imamura S,Matsukawa A,Ohkawara S,et al.Involvement of tumor necrosis factor-alpha, interleukin-1 beta, interleukin-8,and interleukin-1 receptor antagonist in acute lung injury caused by local Shwartzman reaction.Pathol Int,1997,47:16-24.
|
21. |
李洪霞,张进川,赵亚力,等.急性肺损伤大鼠TNF-α、IL-1β、IL-1ra mRNA的表达及药物干预.解放军医学杂志,2005,30:306-309.
|
22. |
Parsons PE,Matthay MA,Ware LB,et al.Elevated plasma levels of soluble TNF receptors are associated with morbidity and mortality in patients with acute lung injury.Am J Physiol Lung Cell Mol Physiol,2005,288:L426-431.
|
23. |
Pugin J,Ricou B,Steinberg KP,et al.Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS,a prominent role for interleukin-1.Am J Respir Crit Care Med,1996,153:1850-1856.
|
24. |
Olman MA,White KE,Ware LB,et al.Pulmonary edema fluid from patients with early lung injury stimulates fibroblast proliferation through IL-1 beta-induced IL-6 expression.J Immunol,2004,172:2668-2677.
|
25. |
Tzouvelekis A,Pneumatikos I,Bouros D.Serum biomarkers in acute respiratory distress syndrome an ailing prognosticator.Respir Res,2005,6:62.
|
26. |
Parsons PE,Eisner MD,Thompson BT,et al.Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury.Crit Care Med,2005,33:1-6.
|
27. |
Stüber F,Wrigge H,Schroeder S,et al.Kinetic and reversibility of mechanical ventilation-associated pulmonary and systemic inflammatory response in patients with acute lung injury.Intensive Care Med,2002,28:834-841.
|
28. |
Riffo-Vasquez Y,Spina D.Role of cytokines and chemokines in bronchial hyperresponsiveness and airway inflammation. Pharmacol Ther,2002,94:185-211.
|
29. |
Hirose M,Murai T,Kawashima H.Elevation of rat plasma P-selectin in acute lung injury.Biochim Biophys Acta,2007,1772:382-389.
|
30. |
Park WY,Goodman RB,Steinberg KP,et al.Cytokine balance in the lungs of patients with acute respiratory distress syndrome.Am J Respir Crit Care Med,2001,164:1896-1903.
|
31. |
Moraes TJ,Chow CW,Downey GP.Proteases and lung injury.Crit Care Med,2003,31:S189-194.
|
32. |
Pugin J,Verghese G,Widmer MC,et al.The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome.Crit Care Med,1999,27:304-312.
|
33. |
Kim DK,Fukuda T,Thompson BT,et al.Bronchoalveolar lavage fluid phospholipase A2 activities are increased in human adult respiratory distress syndrome.Am J Physiol,1995,269:L109-118.
|
34. |
Amat M,Barcons M, Mancebo J,et al.Evolution of leukotriene B4, peptide leukotrienes, and interleukin-8 plasma concentrations in patients at risk of acute respiratory distress syndrome and with acute respiratory distress syndrome:mortality prognostic study.Crit Care Med,2000,28:57-62.
|
35. |
Nuckton TJ,Alonso JA,Kallet RH,et al.Pulmonary dead-space fraction as a risk factor for death in the acute respiratory distress syndrome.N Engl J Med,2002,346:1281-1286.
|
36. |
Abraham E.Coagulation abnormalities in acute lung injury and sepsis.Am J Respir Cell Mol Biol,2000:401-404.
|
37. |
Prabhakaran P,Ware LB,White KE,et al.Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury.Am J Physiol,Lung Cell Mol Physiol,2003,285:20-28.
|
38. |
Matthay MA,Ware LB.Plasma protein C levels in patients with acute lung injury: prognostic significance.Crit Care Med,2004,32:S229-S232.
|
39. |
郭强,黄建安,金钧,等.急性呼吸窘迫综合征患者早期脂蛋白和凝血指标水平的临床意义.中国危重病急救医学,2006,18:380-381.
|